Literature DB >> 10609685

Executive control function: a rational basis for the diagnosis of vascular dementia.

G C Román1, D R Royall.   

Abstract

Problems with diagnostic criteria for vascular dementia (VaD) stem from the inadequacy of the current dementia concept, a paradigm based on amnestic and other cortical deficits typical of Alzheimer disease (AD). However, most cases of VaD are due to subcortical lesions such as Binswanger-type periventricular white matter ischemia, or strokes causing decreased frontal activation and diaschisis-mediated cerebral hypoperfusion. We propose a new definition of dementia based on executive dysfunction and a formal assessment of executive control functions (ECF) for the diagnosis of VaD. The instruments proposed are the rapid screening executive clock-drawing task (CLOX; Royall et al. J Neurol Neurosurg Psychiatry 1998;64:588-94), and the more comprehensive Executive Interview Test (EXIT25; Royall et al. J Am Geriatr Soc 1992;40:122-6). Extensive application of these tests in elderly subjects in retirement communities has shown that both are brief, simple to administer, and more sensitive case-finding tools for cognitively impaired individuals than the Mini-Mental State Examination (MMSE). These three tests (CLOX, EXIT25, MMSE) accurately separate nondemented subjects from those with cortical or subcortical (frontal system) dementias. In addition, for controlled clinical trials of VaD, formal evaluation of motor and frontal sphincter functions--usually not considered part of the dementia syndrome--should also be included. Evaluation of gait and falls, timed-walk, manual dexterity, timed finger-tapping, and frontal bladder control (urge incontinence and nocturia) should improve determination of functional status and disability, and more accurately measure the effects of potential therapies.

Entities:  

Mesh:

Year:  1999        PMID: 10609685     DOI: 10.1097/00002093-199912003-00012

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  24 in total

Review 1.  The clinical manifestations and pathophysiology of cerebral small vessel disease.

Authors:  Ai-Juan Zhang; Xin-Jun Yu; Mei Wang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

2.  Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data.

Authors:  C C Price; A L Jefferson; J G Merino; K M Heilman; D J Libon
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

3.  Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size.

Authors:  Gustavo C Román; Stephen Salloway; Sandra E Black; Donald R Royall; Charles Decarli; Michael W Weiner; Margaret Moline; Dinesh Kumar; Rachel Schindler; Holly Posner
Journal:  Stroke       Date:  2010-04-15       Impact factor: 7.914

4.  Cognitive profile of chronic kidney disease and hemodialysis patients without dementia.

Authors:  James B Post; Adejoke B Jegede; Kel Morin; Ann M Spungen; Erik Langhoff; Mary Sano
Journal:  Nephron Clin Pract       Date:  2010-07-02

5.  Executive function, episodic memory, and Medicare expenditures.

Authors:  Alex C Bender; Andrea M Austin; Francine Grodstein; Julie P W Bynum
Journal:  Alzheimers Dement       Date:  2017-02-04       Impact factor: 21.566

6.  Assessment of free and cued recall in Alzheimer's disease and vascular and frontotemporal dementia with 24-item Grober and Buschke test.

Authors:  Milena Cerciello; Valeria Isella; Alice Proserpi; Costanza Papagno
Journal:  Neurol Sci       Date:  2016-09-26       Impact factor: 3.307

7.  Low dose aspirin and cognitive function in the women's health study cognitive cohort.

Authors:  Jae Hee Kang; Nancy Cook; JoAnn Manson; Julie E Buring; Francine Grodstein
Journal:  BMJ       Date:  2007-04-27

8.  Patterns of late-life depressive symptoms and subsequent declines in cognitive domains.

Authors:  J Cai Gillis; Shun-Chiao Chang; Elizabeth E Devore; Bernard A Rosner; Francine Grodstein; Olivia I Okereke
Journal:  Int J Geriatr Psychiatry       Date:  2016-11-07       Impact factor: 3.485

Review 9.  Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.

Authors:  Dara L Dickstein; Jessica Walsh; Hannah Brautigam; Steven D Stockton; Samuel Gandy; Patrick R Hof
Journal:  Mt Sinai J Med       Date:  2010 Jan-Feb

Review 10.  Vascular dementia: prevention and treatment.

Authors:  Catherine McVeigh; Peter Passmore
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.